169 related articles for article (PubMed ID: 27892604)
1. Interleukin (IL)-6 modulates transforming growth factor-β receptor I and II (TGF-βRI and II) function in epidermal keratinocytes.
Luckett-Chastain LR; Cottrell ML; Kawar BM; Ihnat MA; Gallucci RM
Exp Dermatol; 2017 Aug; 26(8):697-704. PubMed ID: 27892604
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling.
Zhang XL; Topley N; Ito T; Phillips A
J Biol Chem; 2005 Apr; 280(13):12239-45. PubMed ID: 15661740
[TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice.
Luckett-Chastain LR; Gallucci RM
Br J Dermatol; 2009 Aug; 161(2):237-48. PubMed ID: 19438433
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins.
Stockwell BR; Schreiber SL
Chem Biol; 1998 Jul; 5(7):385-95. PubMed ID: 9662508
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
Bourguignon LY; Singleton PA; Zhu H; Zhou B
J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
[TBL] [Abstract][Full Text] [Related]
6. GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5/TGF-βRII heterodimer.
Artz A; Butz S; Vestweber D
Blood; 2016 Jul; 128(4):529-41. PubMed ID: 27235139
[TBL] [Abstract][Full Text] [Related]
7. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling.
Paus R; Foitzik K; Welker P; Bulfone-Paus S; Eichmüller S
J Invest Dermatol; 1997 Oct; 109(4):518-26. PubMed ID: 9326384
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin.
Vorstenbosch J; Nguyen CM; Zhou S; Seo YJ; Siblini A; Finnson KW; Bizet AA; Tran SD; Philip A
J Invest Dermatol; 2017 Mar; 137(3):641-649. PubMed ID: 27866969
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.
Walraven M; Beelen RH; Ulrich MM
J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202
[TBL] [Abstract][Full Text] [Related]
11. Controlling long-term signaling: receptor dynamics determine attenuation and refractory behavior of the TGF-β pathway.
Vizán P; Miller DS; Gori I; Das D; Schmierer B; Hill CS
Sci Signal; 2013 Dec; 6(305):ra106. PubMed ID: 24327760
[TBL] [Abstract][Full Text] [Related]
12. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
Fanayan S; Firth SM; Butt AJ; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
[TBL] [Abstract][Full Text] [Related]
14. Smad2 is involved in Aggregatibacter actinomycetemcomitans-induced apoptosis.
Yoshimoto T; Fujita T; Ouhara K; Kajiya M; Imai H; Shiba H; Kurihara H
J Dent Res; 2014 Nov; 93(11):1148-54. PubMed ID: 25192897
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
Daly AC; Randall RA; Hill CS
Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
17. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
Upton PD; Davies RJ; Tajsic T; Morrell NW
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells.
Li R; Wang Y; Liu Y; Chen Q; Fu W; Wang H; Cai H; Peng W; Zhang X
PLoS One; 2013; 8(3):e58848. PubMed ID: 23544048
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]